Efrain Vazquez, | |
345a Greenwood St, Worcester, MA 01607-1753 | |
(508) 363-0200 | |
Not Available |
Full Name | Efrain Vazquez |
---|---|
Gender | Male |
Speciality | Behavior Technician |
Location | 345a Greenwood St, Worcester, Massachusetts |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1003204363 | NPI | - | NPPES |
1307576 | Medicaid | MA | |
M18463 | Other | MA | BLUE CROSS BLUE SHIELD |
1303295 | Medicaid | MA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
101Y00000X | Counselor | (* (Not Available)) | Secondary |
106S00000X | Behavior Technician | (* (Not Available)) | Primary |
Mailing Address | Practice Location Address |
---|---|
Efrain Vazquez, 345a Greenwood St, Worcester, MA 01607-1753 Ph: (508) 363-0200 | Efrain Vazquez, 345a Greenwood St, Worcester, MA 01607-1753 Ph: (508) 363-0200 |
News Archive
"The United Nations estimates the civil war raging in Syria has left more than 2.5 million people in dire need of food, water, drugs and medical supplies," VOA News reports.
Scientists from the Florida campus of The Scripps Research Institute (TSRI) have been awarded more than $1.4 million from the National Cancer Institute of the National Institutes of Health to create a potential new drug to attack the malignant cells that cause chronic lymphocytic leukemia (CLL), which is the most common leukemia in the Western world.
UCB and U.S. based partner Immunomedics Inc. announced that results from the phase IIB study, EMBLEM, showed that certain doses of epratuzumab were associated with a meaningful and statistically significant reduction in disease activity in adult patients with moderate to severe active SLE.
Patients with a particular type of advanced lung cancer may have a new option based on data presented at the 2005 annual meeting of the American Society of Clinical Oncology showing that combining a drug that cuts off the cancer's blood supply with standard chemotherapy can shrink tumors and extend life.
Most babies can reach out for and eat finger food by six to eight months, according to a study in the January issue of Maternal and Child Nutrition.
› Verified 1 days ago